imaging. This study not only introduces a robust unimolecular NIR fluorescent probe to mitigate false-negative diagnoses in ovarian cancer but also establishes a versatile design strategy for developing multi-enzyme-responsive imaging agents, offering a promising approach to enhance diagnostic accuracy in clinical settings.